Calkovska Andrea, Mokra Daniela, Drgova Anna, Zila Ivan, Javorka Kamil
Department of Physiology, Jessenius Faculty of Medicine, Comenius University, Mala Hora 4, 037 54, Martin, Slovakia.
Eur J Pediatr. 2008 Aug;167(8):851-7. doi: 10.1007/s00431-007-0596-7. Epub 2007 Oct 19.
Surfactant lung lavage is a promising approach in the treatment of meconium aspiration syndrome (MAS). We hypothesise that the enrichment of modified natural surfactant with dextran will enhance meconium clearance from the airspaces during lung lavage and improve lung function in experimental MAS. Human meconium (30 mg/ml; 4 ml/kg) was instilled into the tracheal cannula of anaesthetised and paralysed adult rabbits to induce respiratory failure. The animals were then lavaged with saline (Sal), surfactant without (Surf) and with dextran (Surf+dex). Lung lavage (10 ml/kg in three portions) was performed with diluted surfactant (Curosurf, 10 mg/ml, 100 mg/kg) without or with dextran (3 mg/mg of surfactant phospholipids) or saline and the animals were conventionally ventilated with 100% O(2) for an additional hour. Lung functions were measured prior to and after meconium instillation, and 10, 30 and 60 min after lavage. The recovery of meconium in bronchoalveolar lavage (BAL) fluid was quantified. More meconium solids was recovered in the surfactant-lavaged than in the saline-lavaged groups (Surf: 12.4 +/- 3.9% and Surf+dex: 17.5 +/- 3.5% vs. Sal: 4.8 +/- 1.0%; both P < 0.01). Moreover, more meconium solids was obtained by Curosurf/dextran than by Curosurf-only lavage (P < 0.05). In the Surf group, the values for PaO(2)/FiO(2) were significantly higher than in the controls (at 60 min: 24.5 +/- 4.2 kPa vs.9.1 +/- 2.2 kPa, P < 0.01). An additional increase in oxygenation was seen in the Surf+dex group (at 60 min: 34.2 +/- 8.1 kPa, P vs. Surf group <0.01). The lung-thorax compliance was higher in the Surf+dex group in comparison with the Sal and Surf groups (at 60 min: 9.6 +/- 0.9 vs.7.6 +/- 1.2, P < 0.01 and 8.0 +/- 0.7 ml/kPa/kg, P < 0.05). The enrichment of Curosurf with dextran improves meconium clearance and lung functions in surfactant-lavaged rabbits with meconium aspiration.
表面活性剂肺灌洗是治疗胎粪吸入综合征(MAS)的一种有前景的方法。我们假设用葡聚糖富集改良天然表面活性剂将增强肺灌洗期间胎粪从气腔的清除,并改善实验性MAS中的肺功能。将人胎粪(30mg/ml;4ml/kg)注入麻醉和麻痹的成年兔的气管插管中以诱导呼吸衰竭。然后用盐水(Sal)、不含葡聚糖的表面活性剂(Surf)和含葡聚糖的表面活性剂(Surf+dex)对动物进行灌洗。用稀释的表面活性剂(固尔苏,10mg/ml,100mg/kg)不加或加葡聚糖(3mg/表面活性剂磷脂mg)或盐水进行肺灌洗(10ml/kg分三次),并将动物用100%O₂常规通气额外1小时。在注入胎粪之前和之后以及灌洗后10、30和60分钟测量肺功能。对支气管肺泡灌洗(BAL)液中胎粪的回收进行定量。表面活性剂灌洗组回收的胎粪固体比盐水灌洗组更多(Surf:12.4±3.9%和Surf+dex:17.5±3.5%,而Sal:4.8±1.0%;两者P<0.01)。此外,与仅用固尔苏灌洗相比,用固尔苏/葡聚糖获得的胎粪固体更多(P<0.05)。在Surf组中,PaO₂/FiO₂值显著高于对照组(60分钟时:24.5±4.2kPa对9.1±2.2kPa,P<0.01)。在Surf+dex组中观察到氧合进一步增加(60分钟时:34.2±8.1kPa,与Surf组相比P<0.01)。与Sal组和Surf组相比,Surf+dex组的肺胸顺应性更高(60分钟时:9.6±0.9对7.6±1.2,P<0.01和8.0±0.7ml/kPa/kg,P<0.05)。用葡聚糖富集固尔苏可改善表面活性剂灌洗的胎粪吸入兔的胎粪清除和肺功能。